D.E. Shaw & Co’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-43,800
Closed -$10M 4471
2025
Q4
$10M Buy
43,800
+7,600
+21% +$1.73M 0.01% 1759
2025
Q3
$8.38M Sell
36,200
-37,900
-51% -$7.72M 0.01% 1820
2025
Q2
$13.8M Sell
74,100
-112,300
-60% -$20.9M 0.01% 1267
2025
Q1
$39.1M Buy
186,400
+50,500
+37% +$9.82M 0.05% 584
2024
Q4
$24.1M Sell
135,900
-2,100
-2% -$386K 0.03% 925
2024
Q3
$27.3M Sell
138,000
-28,100
-17% -$5.24M 0.04% 818
2024
Q2
$28.5M Buy
166,100
+72,800
+78% +$12.1M 0.04% 705
2024
Q1
$17M Sell
93,300
-333,800
-78% -$57.5M 0.02% 1013
2023
Q4
$66.2M Buy
427,100
+125,700
+42% +$18.3M 0.1% 389
2023
Q3
$44.9M Sell
301,400
-224,300
-43% -$32.9M 0.07% 470
2023
Q2
$70.8M Buy
525,700
+163,200
+45% +$23.9M 0.11% 327
2023
Q1
$57.8M Buy
362,500
+32,100
+10% +$4.91M 0.09% 381
2022
Q4
$53.4M Buy
330,400
+21,100
+7% +$3.24M 0.09% 408
2022
Q3
$41.5M Sell
309,300
-948,900
-75% -$136M 0.07% 468
2022
Q2
$193M Sell
1,258,200
-309,400
-20% -$47.3M 0.31% 63
2022
Q1
$254M Buy
1,567,600
+966,700
+161% +$140M 0.33% 60
2021
Q4
$81.4M Sell
600,900
-43,000
-7% -$5.08M 0.1% 350
2021
Q3
$69.5M Sell
643,900
-26,700
-4% -$3.05M 0.09% 381
2021
Q2
$75.5M Buy
670,600
+159,100
+31% +$17.9M 0.09% 368
2021
Q1
$55.4M Sell
511,500
-799,678
-61% -$85.5M 0.07% 442
2020
Q4
$140M Buy
1,311,178
+263,200
+25% +$25.3M 0.17% 172
2020
Q3
$91.8M Buy
1,047,978
+482,100
+85% +$45.4M 0.12% 248
2020
Q2
$55.6M Sell
565,878
-12,622
-2% -$1.11M 0.08% 335
2020
Q1
$44.1M Sell
578,500
-21,800
-4% -$1.86M 0.09% 321
2019
Q4
$53.2M Sell
600,300
-339,200
-36% -$28.2M 0.08% 369
2019
Q3
$71.1M Buy
939,500
+511,100
+119% +$35M 0.11% 274
2019
Q2
$31.2M Sell
428,400
-458,500
-52% -$36M 0.05% 540
2019
Q1
$71.5M Buy
886,900
+345,200
+64% +$28.2M 0.12% 267
2018
Q4
$49.9M Buy
541,700
+34,300
+7% +$3.02M 0.09% 349
2018
Q3
$48M Buy
507,400
+117,600
+30% +$11.2M 0.08% 421
2018
Q2
$36.1M Buy
389,800
+76,200
+24% +$7.44M 0.06% 468
2018
Q1
$29.7M Sell
313,600
-155,200
-33% -$17M 0.05% 508
2017
Q4
$45.3M Buy
468,800
+443,600
+1,760% +$41.8M 0.08% 379
2017
Q3
$2.24M Buy
+25,200
New +$1.92M ﹤0.01% 1933
2017
Q2
Sell
-20,000
Closed -$1.3M 3334
2017
Q1
$1.3M Sell
20,000
-70,000
-78% -$4.4M ﹤0.01% 2132
2016
Q4
$5.64M Sell
90,000
-106,100
-54% -$6.48M 0.01% 1283
2016
Q3
$12.4M Buy
196,100
+106,100
+118% +$6.87M 0.03% 782
2016
Q2
$5.57M Sell
90,000
-20,000
-18% -$1.22M 0.01% 1224
2016
Q1
$6.28M Sell
110,000
-349,960
-76% -$19.5M 0.01% 1129
2015
Q4
$27.2M Sell
459,960
-80,000
-15% -$4.61M 0.05% 499
2015
Q3
$29.4M Hold
539,960
0.06% 466
2015
Q2
$36.3M Buy
539,960
+389,960
+260% +$25.5M 0.07% 416
2015
Q1
$8.78M Sell
150,000
-26,600
-15% -$1.61M 0.02% 1045
2014
Q4
$11.6M Sell
176,600
-100,000
-36% -$6.3M 0.02% 1014
2014
Q3
$16M Buy
276,600
+100,000
+57% +$5.55M 0.03% 812
2014
Q2
$9.97M Sell
176,600
-40,000
-18% -$2.1M 0.02% 1104
2014
Q1
$11.1M Sell
216,600
-20,000
-8% -$1.01M 0.02% 996
2013
Q4
$12.5M Buy
236,600
+40,000
+20% +$1.97M 0.03% 981
2013
Q3
$8.79M Buy
196,600
+74,600
+61% +$3.31M 0.02% 1119
2013
Q2
$5.04M Buy
+122,000
New +$5.34M 0.01% 1352

Other funds holding ABBV